Skip to content

Free cash flow at other companies

CVS Health logo
CVS HealthCVS
$3.4B-10.8%
Amazon logo
AmazonAMZN
-$18.17B-127%
Doximity logo
DoximityDOCS
$81.61M-17.1%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$34.92M-507%
Cencora logo
CencoraCOR
-$2.42B+14.2%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%

Valuation

See full
Market cap$934.74M-43.1%
Enterprise value$1.24B-34.1%
P/E45.5×-12.3×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Calculated from GoodRx Holdings, Inc.’s reported figures.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s free cash flow?
GoodRx Holdings, Inc. (GDRX) reported free cash flow of $10.7M in Q1 2026.
How has GoodRx Holdings, Inc.'s free cash flow changed year-over-year?
GoodRx Holdings, Inc.'s free cash flow increased by 15.4% year-over-year, from $9.27M to $10.7M.
What is the long-term trend for GoodRx Holdings, Inc.'s free cash flow?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s free cash flow has grown at a -1.4% compound annual growth rate (CAGR), from $174.21M to $164.38M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.